Tenet Healthcare (THC) Cash from Financing Activities (2009 - 2026)

Tenet Healthcare has disclosed Cash from Financing Activities across 18 years of filings, most recently posting -$1.2 billion for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$1.2 billion, down 91.36% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.0 billion (down 79.01% YoY), and the FY2025 annual result was -$2.4 billion, up 34.84% from the prior year.
• Cash from Financing Activities came in at -$1.2 billion for Q1 2026 at Tenet Healthcare, down from -$434.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of -$33.0 million in Q2 2022 to a low of -$2.7 billion in Q1 2024.
• The 5-year median for Cash from Financing Activities is -$372.0 million (2024), against an average of -$596.6 million.
• Across the five-year window, Cash from Financing Activities jumped 88.28% in 2022 and tumbled 943.53% in 2024, its largest moves.
• Tenet Healthcare's Cash from Financing Activities stood at -$465.0 million in 2022, then surged by 31.83% to -$317.0 million in 2023, then declined by 17.35% to -$372.0 million in 2024, then dropped by 16.67% to -$434.0 million in 2025, then plunged by 185.71% to -$1.2 billion in 2026.
• The last three Cash from Financing Activities figures came in at -$1.2 billion (Q1 2026), -$434.0 million (Q4 2025), and -$323.0 million (Q3 2025), per Business Quant data.